Thermo Fisher Scientific | TMO - Ebitda

Stock Price
487.39
Daily Change
-5.21 -1.06%
Monthly
5.41%
Yearly
-21.39%
Q3 Forecast
488.51

Thermo Fisher Scientific reported $3.06B in EBITDA for its fiscal quarter ending in June of 2025.




Ebitda Change Date
Abbott USD 3.05B 870M Jun/2025
Agilent USD 466M 14M Jul/2025
Becton, Dickinson and Co. USD 1.47B 81M Jun/2025
Bio Techne USD 115.58M 47.73M Jun/2025
Bio-Rad Laboratories USD 467.2M 372.2M Jun/2025
Boston Scientific USD 1.36B 16M Mar/2025
Bruker USD 128.1M 27.1M Jun/2025
Charles River Laboratories USD 220.89M 2.01M Jun/2025
Danaher USD 1.34B 543M Jun/2025
Dentsply International USD 197M 45M Jun/2025
Edwards Lifesciences USD 411.3M 15.3M Mar/2025
Exact Sciences USD 138.22M 173.88M Jun/2025
General Electric Aerospace USD 2.1B 720M Mar/2025
Henry Schein USD 256M 0 Jun/2025
Hologic USD 334M 26.7M Jun/2025
Illumina USD 399M 168M Jun/2025
Intuitive Surgical USD 898.7M 317.2M Jun/2025
IQVIA Holdings USD 910M 112M Jun/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
Medtronic USD 2.31B 400M Jul/2025
Mettler Toledo International USD 295.89M 43.87M Jun/2025
Myriad Genetics USD -17800000 15.7M Mar/2025
Olympus JPY 32.57B 38.11B Jun/2025
Quest Diagnostics USD 570M 65M Jun/2025
Repligen USD 32.18M 9.36M Jun/2025
Revvity USD 209.29M 22.24M Jun/2025
Stryker USD 1.46B 49M Jun/2025
Thermo Fisher Scientific USD 3.06B 541M Jun/2025
Veracyte USD 35.78M 29.25M Jun/2025
Waters USD 276.28M 74.81M Jun/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025